BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27170300)

  • 1. Exploring the Impact of Short- and Long-Term Hydrocortisone Replacement on Cognitive Function, Quality of Life and Catecholamine Secretion: A Pilot Study.
    Harbeck B; Danneberg S; Rahvar AH; Haas CS; Lehnert H; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2016 Sep; 41(3):341-7. PubMed ID: 27170300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
    Harbeck B; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency.
    Bleicken B; Hahner S; Loeffler M; Ventz M; Decker O; Allolio B; Quinkler M
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):297-304. PubMed ID: 19508599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hair cortisol content in patients with adrenal insufficiency on hydrocortisone replacement therapy.
    Gow R; Koren G; Rieder M; Van Uum S
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):687-93. PubMed ID: 21521272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency.
    Rousseau E; Joubert M; Trzepla G; Parienti JJ; Freret T; Vanthygem MC; Desailloud R; Lefebvre H; Coquerel A; Reznik Y;
    PLoS One; 2015; 10(8):e0135975. PubMed ID: 26317782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-release hydrocortisone and its benefits on cognitive function and quality of sleep.
    Krekeler C; Kropp P; Blacha AK; Rahvar AH; Harbeck B
    Endocrine; 2021 Apr; 72(1):223-233. PubMed ID: 33625720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of two different doses of hydrocortisone on cognition in patients with secondary adrenal insufficiency--results from a randomized controlled trial.
    Werumeus Buning J; Brummelman P; Koerts J; Dullaart RP; van den Berg G; van der Klauw MM; Tucha O; Wolffenbuttel BH; van Beek AP
    Psychoneuroendocrinology; 2015 May; 55():36-47. PubMed ID: 25705800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
    Isidori AM; Venneri MA; Graziadio C; Simeoli C; Fiore D; Hasenmajer V; Sbardella E; Gianfrilli D; Pozza C; Pasqualetti P; Morrone S; Santoni A; Naro F; Colao A; Pivonello R; Lenzi A
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):173-185. PubMed ID: 29229498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired attention in patients with adrenal insufficiency - Impact of unphysiological therapy.
    Blacha AK; Rahvar AH; Flitsch J; van de Loo I; Kropp P; Harbeck B
    Steroids; 2021 Mar; 167():108788. PubMed ID: 33412217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiometabolic and psychological effects of dual-release hydrocortisone: a cross-over study.
    Dineen R; Martin-Grace J; Ahmed KMS; Frizelle I; Gunness A; Garrahy A; Hannon AM; O'Reilly MW; Smith D; McDermott J; Healy ML; Agha A; Pazderska A; Gibney J; Thompson CJ; Behan LA; Sherlock M
    Eur J Endocrinol; 2021 Feb; 184(2):253-265. PubMed ID: 33513125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life in patients with adrenal insufficiency correlates stronger with hydrocortisone dosage, than with long-term systemic cortisol levels.
    Andela CD; Staufenbiel SM; Joustra SD; Pereira AM; van Rossum EF; Biermasz NR
    Psychoneuroendocrinology; 2016 Oct; 72():80-6. PubMed ID: 27388687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments.
    Johannsson G; Skrtic S; Lennernäs H; Quinkler M; Stewart PM
    Curr Med Res Opin; 2014 Sep; 30(9):1833-47. PubMed ID: 24849526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial.
    Werumeus Buning J; Konopka KH; Brummelman P; Koerts J; Dullaart RPF; van den Berg G; van der Klauw MM; Tucha O; Wolffenbuttel BHR; van Beek AP
    PLoS One; 2017; 12(7):e0180326. PubMed ID: 28686664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor quality of life and sleep in patients with adrenal insufficiency-another cause of increased mortality?
    Blacha AK; Kropp P; Rahvar AH; Flitsch J; van de Loo I; Harbeck B
    Ir J Med Sci; 2022 Aug; 191(4):1653-1658. PubMed ID: 34389925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrocortisone Dose Influences Pain, Depressive Symptoms and Perceived Health in Adrenal Insufficiency: A Randomized Controlled Trial.
    Werumeus Buning J; Brummelman P; Koerts J; Dullaart RP; van den Berg G; van der Klauw MM; Sluiter WJ; Tucha O; Wolffenbuttel BH; van Beek AP
    Neuroendocrinology; 2016; 103(6):771-8. PubMed ID: 26646751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Impact of Urinary Cortisol in the Assessment of Hydrocortisone Replacement Therapy.
    Haas CS; Rahvar AH; Danneberg S; Lehnert H; Moenig H; Harbeck B
    Horm Metab Res; 2016 Sep; 48(9):571-4. PubMed ID: 27300473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency.
    Quinkler M; Miodini Nilsen R; Zopf K; Ventz M; Øksnes M
    Eur J Endocrinol; 2015 May; 172(5):619-26. PubMed ID: 25656494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy.
    Noppe G; van Rossum EF; Vliegenthart J; Koper JW; van den Akker EL
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):820-5. PubMed ID: 25039686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian variation in serum cortisol during hydrocortisone replacement is not attributable to changes in cortisol-binding globulin concentrations.
    Chung TT; Gunganah K; Monson JP; Drake WM
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):496-500. PubMed ID: 26603673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel strategies for hydrocortisone replacement.
    Debono M; Price JN; Ross RJ
    Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):221-32. PubMed ID: 19500765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.